KLK3 and neoplasm: Yang et al. investigated on 10,089 favorable intermediate risk patients (Gleason pattern 3 + 4, PSA < 10 ng/mL, cT 1c-2a) and found out that adverse surgical pathology (tumor upgrading and/or upstaging) occurred in 30.3%.